ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

DCPC Board Okays Recompetition Of Computer Contract

May 30, 1986